ArticleAmerican journal of hematology2026

Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Vijaya Raj Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.